Skip to Content

Nevirapine Teva

Licence status
Withdrawn: 06/03/2023
Active substances
Nevirapine
Dosage Form
Tablet
Licence number
EU/1/09/598/1-4
Licence holder
Teva Pharma B.V.

Licence information

ATC code
J05AG Non-nucleoside reverse transcriptase inhibitors, J05AG01 nevirapine
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
30/11/2009

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie